The relevance of bare-metal stent in the therapy of coronary artery disease in 2020
First percutaneous transluminal coronary angioplasty (PTCA) using an expandable balloon was performed by Andreas Gruentzig in 1977. Since then, the process has seen exponential development. Stent deployment was the most important milestone in this journey. An original stent made of metals or metal a...
Main Author: | Saumitra Ray |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Journal of Indian College of Cardiology |
Subjects: | |
Online Access: | http://www.joicc.org/article.asp?issn=1561-8811;year=2021;volume=11;issue=1;spage=1;epage=4;aulast=Ray |
Similar Items
-
POR QUÉ USAR PREFERENTEMENTE STENTS NO FARMACOACTIVOS / Why it is preferable to use non-drug-eluting stents
by: Rosa Lázaro García, et al.
Published: (2013-10-01) -
Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
by: Talha Ahmed, et al.
Published: (2022-10-01) -
Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
by: Xiao-Zeng Wang, et al.
Published: (2015-01-01) -
Drug-eluting coronary stents in clinical practice: lessons from the «BAsel Stent Kosten-Effektivitäts Trials» (BASKET)
by: Swiss Medical Weekly
Published: (2011-08-01) -
Natural history of coronary stents: 14 year follow-up of drug eluting stents versus bare metal stents
by: Rohit Sunil Walse, et al.
Published: (2023-11-01)